SEALSQ Corp: Vice president Enguent Jean-Pierre sold 35,000 shares

What happened

• Enguent Jean-Pierre, Vice president, R&DSS, exercised options for 35,000 shares on Oct 5, 2026 at $0.01 (cost $350) and sold 35,000 shares on Oct 6, 2026 at a weighted average price of $2.46 for $85,936.
• The filing also reports a grant of 50,000 derivative shares on Oct 5, 2026 at $0.00 and an additional exercise/conversion of 35,000 derivative shares on Oct 5, 2026 recorded at $0.00.

Key details

• Oct 5, 2026 — exercise/conversion (M): 35,000 shares acquired at $0.01, amount $350.
• Oct 5, 2026 — grant/award (A): 50,000 derivative shares at $0.00, amount $0.
• Oct 5, 2026 — exercise/conversion (M): 35,000 derivative shares disposed at $0.00, amount $0.
• Oct 6, 2026 — sale (S): 35,000 shares sold at a weighted average price of $2.46, total $85,936 (sales executed in multiple transactions at prices from $2.42 to $2.49).
• Shares owned after the transactions: not stated in the Form 4 supplied here.
• Footnotes: the sales and the options exercise were effected pursuant to a Rule 10b5-1 trading plan adopted Oct 13, 2025; the reported sale price is a weighted average and the filer will provide a breakdown of prices on request.

Why it may matter

• The filing shows options were exercised on Oct 5, 2026 and 35,000 of the resulting shares were sold on Oct 6, 2026; the sale prices were reported as a weighted average across multiple trades.
• The filing does not show why the insider traded or why the company acted.